Bayrak EBT Taban Sanayi ve Ticaret Anonim Sirketi Valuation
Is BAYRK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BAYRK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BAYRK (TRY17.27) is trading below our estimate of fair value (TRY40.41)
Significantly Below Fair Value: BAYRK is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BAYRK?
Key metric: As BAYRK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for BAYRK. This is calculated by dividing BAYRK's market cap by their current
revenue.
What is BAYRK's PS Ratio?
PS Ratio
5.5x
Sales
₺147.51m
Market Cap
₺813.85m
BAYRK key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
MEGAP Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi
0.1x
n/a
US$22.40m
No more companies available in this PS range
1 Company
Estimated Growth
Market Cap
No more companies
Price-To-Sales vs Industry: BAYRK is expensive based on its Price-To-Sales Ratio (5.5x) compared to the TR Chemicals industry average (2.7x).
Price to Sales Ratio vs Fair Ratio
What is BAYRK's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
BAYRK PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
5.5x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate BAYRK's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.